These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
259 related items for PubMed ID: 7529286
1. NK cell response to viral infections in beta 2-microglobulin-deficient mice. Tay CH, Welsh RM, Brutkiewicz RR. J Immunol; 1995 Jan 15; 154(2):780-9. PubMed ID: 7529286 [Abstract] [Full Text] [Related]
2. Inability of interferon to protect virus-infected cells against lysis by natural killer (NK) cells correlates with NK cell-mediated antiviral effects in vivo. Bukowski JF, Welsh RM. J Immunol; 1985 Nov 15; 135(5):3537-41. PubMed ID: 2413125 [Abstract] [Full Text] [Related]
3. Elevated natural killer cell-mediated cytotoxicity, plasma interferon, and tumor cell rejection in mice persistently infected with lymphocytic choriomeningitis virus. Bukowski JF, Biron CA, Welsh RM. J Immunol; 1983 Aug 15; 131(2):991-6. PubMed ID: 6190947 [Abstract] [Full Text] [Related]
8. The IFN regulatory factor 7-dependent type I IFN response is not essential for early resistance against murine cytomegalovirus infection. Steinberg C, Eisenächer K, Gross O, Reindl W, Schmitz F, Ruland J, Krug A. Eur J Immunol; 2009 Apr 15; 39(4):1007-18. PubMed ID: 19283778 [Abstract] [Full Text] [Related]
9. IL-2-dependent NK cell responses discovered in virus-infected beta 2-microglobulin-deficient mice. Su HC, Orange JS, Fast LD, Chan AT, Simpson SJ, Terhorst C, Biron CA. J Immunol; 1994 Dec 15; 153(12):5674-81. PubMed ID: 7989765 [Abstract] [Full Text] [Related]
11. Loss or mismatch of MHC class I is sufficient to trigger NK cell-mediated rejection of resting lymphocytes in vivo - role of KARAP/DAP12-dependent and -independent pathways. Oberg L, Johansson S, Michaëlsson J, Tomasello E, Vivier E, Kärre K, Höglund P. Eur J Immunol; 2004 Jun 15; 34(6):1646-53. PubMed ID: 15162434 [Abstract] [Full Text] [Related]
12. Characterization of early IL-12, IFN-alphabeta, and TNF effects on antiviral state and NK cell responses during murine cytomegalovirus infection. Orange JS, Biron CA. J Immunol; 1996 Jun 15; 156(12):4746-56. PubMed ID: 8648121 [Abstract] [Full Text] [Related]
14. NK cell trafficking and cytokine expression in splenic compartments after IFN induction and viral infection. Salazar-Mather TP, Ishikawa R, Biron CA. J Immunol; 1996 Oct 01; 157(7):3054-64. PubMed ID: 8816415 [Abstract] [Full Text] [Related]
15. Purification and target cell range of in vivo elicited blast natural killer cells. Biron CA, Pedersen KF, Welsh RM. J Immunol; 1986 Jul 15; 137(2):463-71. PubMed ID: 3722814 [Abstract] [Full Text] [Related]
16. Window of vulnerability of vaccinia virus-infected cells to natural killer (NK) cell-mediated cytolysis correlates with enhanced NK cell triggering and is concomitant with a decrease in H-2 class I antigen expression. Brutkiewicz RR, Klaus SJ, Welsh RM. Nat Immun; 1992 Jul 15; 11(4):203-14. PubMed ID: 1421956 [Abstract] [Full Text] [Related]
17. Expression of asialo GM1 and other antigens and glycolipids on natural killer cells and spleen leukocytes in virus-infected mice. Yang H, Yogeeswaran G, Bukowski JF, Welsh RM. Nat Immun Cell Growth Regul; 1985 Jul 15; 4(1):21-39. PubMed ID: 3875791 [Abstract] [Full Text] [Related]
18. The effect of the Cmv-1 resistance gene, which is linked to the natural killer cell gene complex, is mediated by natural killer cells. Scalzo AA, Fitzgerald NA, Wallace CR, Gibbons AE, Smart YC, Burton RC, Shellam GR. J Immunol; 1992 Jul 15; 149(2):581-9. PubMed ID: 1378069 [Abstract] [Full Text] [Related]
19. Transfection of beta 2-microglobulin restores IFN-mediated protection from natural killer cell lysis in YAC-1 lymphoma variants. Ljunggren HG, Sturmhöfel K, Wolpert E, Hämmerling GJ, Kärre K. J Immunol; 1990 Jul 01; 145(1):380-6. PubMed ID: 2113557 [Abstract] [Full Text] [Related]
20. The NK receptor KLRG1 is dispensable for virus-induced NK and CD8+ T-cell differentiation and function in vivo. Gründemann C, Schwartzkopff S, Koschella M, Schweier O, Peters C, Voehringer D, Pircher H. Eur J Immunol; 2010 May 01; 40(5):1303-14. PubMed ID: 20201037 [Abstract] [Full Text] [Related] Page: [Next] [New Search]